nalidixic acid has been researched along with Koch's Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muzanyi, G | 1 |
| Peace, A | 1 |
| Wamuntu, B | 1 |
| Joseph, A | 1 |
| Nassali, J | 1 |
| Aboul-Fadl, T | 1 |
| Bin-Jubair, FA | 1 |
| Aboul-Wafa, O | 1 |
| de Kantor, IN | 1 |
| Eykyn, SJ | 1 |
| Phillips, I | 1 |
1 review available for nalidixic acid and Koch's Disease
| Article | Year |
|---|---|
Advances in antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicin | 1969 |
3 other studies available for nalidixic acid and Koch's Disease
| Article | Year |
|---|---|
The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures.
Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Bacteria; Bacteriological Techniques; Fungi; Huma | 2021 |
Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
Topics: Antitubercular Agents; Drug Design; Humans; Hydrazines; Isatin; Models, Molecular; Mycobacterium; Na | 2010 |
[New active drugs against the tuberculosis bacillus and other mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Humans; Lactams; Mycobacterium; Mycobacterium avium; Mycobacterium | 1986 |